Marina Bay Sands, Singapore
Marina Bay Sands, Singapore
Enable the Future of Biomanufacturing in Asia: Digital, Continuous, and AI-Driven
Learn how APAC, EU and US leaders are incorporating machine learning to modernize facilities, reduce approval timelines, and master the transition to connected manufacturing across the full product lifecycle
Stay Up-to-Date on BioProcess International Asia 2026
Your Blueprint for Bioprocessing Success in Asia
The biopharma industry in Asia is rapidly evolving, but challenges like regulatory complexity, scaling digital transformation, and achieving operational excellence remain. BPI Asia 2026 is designed to help you overcome these hurdles with actionable insights, proven strategies, and unparalleled networking opportunities.
Intensified & Continuous Bioprocessing
The Problem:
The regulatory landscape in Asia is fragmented and constantly evolving, creating uncertainty for biopharma companies. Misaligned global and regional requirements, coupled with the rapid emergence of new modalities like cell and gene therapies, make compliance a daunting task.
The Solution:
BPI Asia 2026 brings together regulatory experts and industry leaders to provide clarity on navigating these complexities. Gain actionable insights into aligning with global expectations, managing inspection readiness, and ensuring compliance for innovative therapies.
Scaling AI and digital transformation in bioprocessing
The Problem:
While AI and digital tools promise to revolutionize bioprocessing, many organizations struggle to move beyond pilot projects. Challenges include integrating legacy systems, building scalable data infrastructure, and ensuring cross-functional adoption.
The Solution :
At BPI Asia 2026, you’ll learn from real-world case studies of enterprise-scale AI implementation. Discover how leading organizations are building digital backbones, automating processes, and embedding analytics into daily operations to drive measurable impact.
Improving efficiency and quality in manufacturing.
The Problem:
Biomanufacturing is under pressure to deliver higher yields, faster timelines, and consistent quality, all while maintaining cost efficiency. Variability in processes and the need for advanced control strategies add to the complexity.
The Solution:
BPI Asia 2026 showcases cutting-edge advancements in digital manufacturing, process analytical technologies (PAT), and advanced process control. Learn how to reduce deviations, improve process robustness, and achieve operational excellence through proven strategies and tools.
Network with Asia's Biopharma Decision-Makers Under One Roof
Connect directly with decision-makers controlling R&D budgets who are actively shaping the future of biologics across Asia-Pacific.
Biopharmaceutical and Biotechnology Innovators
Gain insights from leading scientists and industry leaders driving product development and research.
Research & Development
Explore how AI, automation, and advanced analytics are reshaping biologics development and manufacturing.
What’s New for 2026?
- Real-world case studies from APAC organizations demonstrating measurable operational impact
- A stronger focus on enterprise-level digital transformation, governance, and scaling.
- Regional leadership perspectives from Japan, Singapore, China, and Korea.
- Dedicated sessions on AI validation, inspection readiness, and regulatory engagement.
- Top sessions featured US and Europe companies ahead of the game, sharing their strategies and lessons learned
Program Highlights
Monday, August 31st: Pre-Conference Workshop
Developing a Global Regulatory Strategy to Expedite Product Launch
Led by Jack Wong, CEO and Founder of the Asia Regulatory Professionals Association (ARPA), this interactive workshop will provide practical guidance on navigating global regulatory requirements. Key topics include:
- Frameworks for early decision-making to define optimal regulatory pathways.
- Strategies for expediting product launches in key global markets.
- Best practices for effective communication with regulatory agencies.
Tuesday, September 1st: Plenary Sessions
Keynote Address 1: The State of Digital Transformation in Bioprocessing – An APAC Perspective
Presented by Janice Reisman, Takeda, Japan, this keynote will explore:
- The current maturity level of digital adoption across APAC biomanufacturing organizations.
- Case examples of moving from siloed data to integrated digital ecosystems.
- A roadmap for building intelligent, scalable bioprocessing operations in Asia.
Tuesday, September 1st: Breakout Sessions
Digital Strategy, Data Foundations, and Execution
Explore how leading biopharma companies are building the data infrastructure and governance frameworks necessary for scalable digital transformation. Topics include:
- System integration and data standardization.
- Real-world execution strategies and lessons learned.
- Case studies demonstrating measurable operational gains.
Panel Discussion: Why Digital Transformation Fails and How APAC Organizations are Fixing It
Moderated by Kenji Yamamoto, Chugai Pharmaceutical, Japan, this panel will address:
- Organizational and cultural barriers to digital success.
- Strategies to secure executive buy-in and cross-functional alignment.
- Real examples of turning failed initiatives into scalable programs.
Wednesday, September 2nd: Key Sessions
AI in Action Across the Bioprocess Lifecycle
This session will demonstrate how AI delivers value across the full bioprocess lifecycle, from cell line development to commercial manufacturing.
From Pilot Projects to Enterprise Impact: Scaling AI in Biomanufacturing
Learn how to move from proof-of-concept to enterprise-wide AI deployment, with insights into ROI metrics, cross-site standardization, and organizational change management.
AI in Cell Line Development & Upstream Processing
Explore predictive modeling for clone selection, AI-assisted media optimization, and process intensification enabled by data-driven insights.
Respected Speakers and Keynotes at BioProcess International Asia 2025
Hear from leading companies ahead of the curve, showcasing their success stories and strategies for digital transformation and biomanufacturing excellence.
Who You'll Meet
+
Global scientists, executives, and technology leaders
%
of participants hold Director-level positions or higher
/10
Top Global Pharmaceutical Companies represented
Network Your Way: New Opportunities to Connect, Collaborate, and Grow
Connecting Industry & Academia
Submit a scientific poster display and showcase your innovations to an elite gathering of international professionals and executives from across the biopharmaceutical development and production landscape.
Networking Reception
Connect with industry leaders from across Asia at the evening networking reception. Build new relationships in a casual setting designed for conversation and connection.
Exhibit Hall
Our exhibit hall features the industry's latest technologies designed to accelerate your novel biotherapeutic towards commercial success.
Engage the BioProcess International Asia Audience!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact our team at Partners@informaconnectls.com for pricing and package options.